» Authors » Tommy Saing

Tommy Saing

Explore the profile of Tommy Saing including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 827
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Valdivia A, Ly J, Gonzalez L, Hussain P, Saing T, Islamoglu H, et al.
AIDS Res Hum Retroviruses . 2017 Apr; 33(9):905-918. PMID: 28398068
HIV infects and destroys CD4+ T cells leading to a compromised immune system. In a double-blinded study, a group of HIV-infected individuals with CD4+ T cell counts below 350 cells/mm...
2.
Saing T, Valdivia A, Hussain P, Ly J, Gonzalez L, Guilford F, et al.
Data Brief . 2016 Aug; 8:1044-7. PMID: 27508262
Our most recent data indicate differences in the levels of pro-inflammatory cytokines (IL-1β, IL-17, and IL-6) and malondialdehyde (MDA), a stable end-product of lipid peroxidation in the plasma samples between...
3.
Saing T, Lagman M, Castrillon J, Gutierrez E, Guilford F, Venketaraman V
BBA Clin . 2016 Jun; 6:38-44. PMID: 27335804
HIV-1 positive individuals are at high risk for susceptibility to both pulmonary tuberculosis (TB) and extra-pulmonary TB, including TB meningitis (TBM) which is an extreme form of TB. The goals...
4.
Ly J, Lagman M, Saing T, Kaur Singh M, Tudela E, Morris D, et al.
J Interferon Cytokine Res . 2015 Jul; 35(11):875-87. PMID: 26133750
Cytokines are signaling biomolecules that serve as key regulators of our immune system. CD4(+) T-cells can be grouped into 2 major categories based on their cytokine profile: T-helper 1 (TH1)...
5.
Lagman M, Ly J, Saing T, Kaur Singh M, Tudela E, Morris D, et al.
PLoS One . 2015 Mar; 10(3):e0118436. PMID: 25790445
Tuberculosis (TB) remains an eminent global burden with one third of the world's population latently infected with Mycobacterium tuberculosis (M. tb). Individuals with compromised immune systems are especially vulnerable to...
6.
Ghochikyan A, Petrushina I, Davtyan H, Hovakimyan A, Saing T, Davtyan A, et al.
Neurosci Lett . 2013 Dec; 560:86-91. PMID: 24361548
Immunotherapeutic approaches reducing α-synuclein deposits may provide therapeutic benefit for Dementia with Lewy Bodies (DLB). Immunization with full-length human α-synuclein (hα-Syn) protein in a Parkinson's disease mouse model decreased the...
7.
Henkins K, Sokolow S, Miller C, Vinters H, Poon W, Cornwell L, et al.
Brain Pathol . 2012 Apr; 22(6):826-33. PMID: 22486774
Like amyloid beta (Aβ) oligomers, tau aggregates are increasingly recognized as potential key toxic intermediates in Alzheimer's disease (AD) and as therapeutic targets. P-tau co-localizes with Aβ in cortical AD...
8.
Arold S, Sullivan P, Bilousova T, Teng E, Miller C, Poon W, et al.
Acta Neuropathol . 2011 Oct; 123(1):39-52. PMID: 22020632
The apolipoprotein E4 allele (APOE4) contributes to Alzheimer's disease (AD) risk and APOE2 is protective, but the relevant cellular mechanisms are unknown. We have used flow cytometry analysis to measure...
9.
Saing T, Dick M, Nelson P, Kim R, Cribbs D, Head E
J Neurotrauma . 2011 Oct; 29(6):1054-70. PMID: 22017610
Dementia pugilistica (DP) is associated with chronic traumatic brain injury (CTBI), and leads to a "punch drunk" syndrome characterized by impairments in memory and executive function, behavioral changes, and motor...
10.
Snigdha S, Berchtold N, Astarita G, Saing T, Piomelli D, Cotman C
PLoS One . 2011 Sep; 6(9):e24652. PMID: 21931796
Lifestyle interventions such as diet, exercise, and cognitive training represent a quietly emerging revolution in the modern approach to counteracting age-related declines in brain health. Previous studies in our laboratory...